# Commission Regulation (EEC) No 2061/89 of 7 July 1989 concerning the classification of certain goods in the combined nomenclature, Annex

Extent: E+W+S+N.I.

Description of the goods
Classification (CN code)
Reasons
(1)
(2)
(3)
1.
Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from food lacking in proteins.
Composition per 100 g of the preparation:
L-histidine: 4,2 g
L-isoleucine: 4,2 g
L-leucine: 4,2 g
L-lysine: 4,2 g
L-methionine: 4,2 g
L-phenylalanine: 4,2 g
L-threonine: 4,2 g
L-tryptophan: 4,2 g
L-valine: 4,2 g
L-cystine: 2,8 g
L-glycine: 2,8 g
L-cysteïn: 2,8 g
L-tyrosine: 2,8 g
L-taurine: 2,8 g
L-arginine: 2,8 g
L-ornithine: 2,8 g
L-glutamine: 2,8 g
L-alanine: 1,4 g
L-aspartic acid: 1,4 g
L-glutamic acid: 1,4 g
L-citruline: 1,4 g
L-serine: 1,4 g
L-proline: 1,4 g
L-glutathion: 1,4 g
L-carnitine: 1,4 g
Cellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g
2106 90 92
Classfication is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 92.
The products is a food supplement (see also HS Explanatory Note to heading 21.06)
2.
Preparation in the form of tablets put up in packings for retail sale with 0instructions on dosage and composition to counter, in particular, deficiency resulting from the growth of children.
Composition per 100 g of the preparation:
glycine: 36,2 g
L-ornithine: 27,2 g
L-tryptophan: 9,1 g
Niacinamide: 2,2 g
Vitamin B6: 0,8 g;
Cellulose, stearic acid, magnesium stearate, silicon dioxide, and food glaze containing protein: ad 100 g
2106 90 92
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 92.
The product is a food supplement (see also HS Explanatory Note to heading 21.06)
3.
Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition to counter deficiency resulting from the menstruation of women.
Composition per 100 g of the preparation:
Oil of evening primrose: 11,4 g
Vitamin B6: 6,8 g
Magnesium oxide: 5,7 g
Calcium carbonate: 2,9 g
Herbal mixture: 2,4 g
Potassium gluconate: 2,3 g
Folic acid: 0,009 g
Cellulose, stearic acid, magnesium stearate, silicon dioxide and food glaze containing protein: ad 100 g
2106 90 92
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 92.
The product is a food supplement (see also HS code Explanatory Note to heading 21.06)
4.
Preparation in the form of tablets put up in packings for retail sale with instructions on dosage and composition, to ensure a balance of substances contained in hair.
Each tablet of approximately 2g contains:
Biotin: 500 μg
L-Cysteine: 150 mg
Choline bitartrate: 125 mg
Inositol: 62,5 mg
Vitamin B12: 12,5 μg
Folic acid: 400 μg
Ascorbic acid: 150 mg
Manganese gluconate: 5 mg
Para aminobenzoic acid: 37,5 mg
Niacinamide: 15 mg
Panothenic acid: 50 mg
Vitamin B6: 37,5 mg
Zinc gluconate: 15 mg
Ferrous gluconate: 10 mg
Iodine: 75 μg
Copper gluconate: 1 mg
Millet extract: 200 mg
In a base containing:
Beta carotene, aloe vera, amino acids, cellulose, stearic acid and food glaze containing protein
2106 90 92
Classification is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 2106, 2106 90 and 2106 90 92.
The product is a food supplement (see also HS Explanatory Note to heading 21.06)
5.
Preparation in the form of tablets put up in packages for retail sale with instructions on dosage and composition, to counter deficiency in vitamin C.
Each tablet weighing 750 mg contains:
Ascorbic acid: 500 mg
Rose hip powder, cellulose, vegetable stearine, botanical oil solids, magnesium stearate, silicon dioxide and food glaze containing protein: 250 mg.
3004 50 00
Classification is determined by General Rules 1 and 6 for the interpretation of the combined nomenclature, Additional Note 1 to Chapter 30 and by the wording of the CN codes 3004 , 3004 50 and 3004 50 00 .
See also the Combined Nomenclature Explanatory Notes to Chapter 30 (General).
As regards the recommended daily allowance (RDA) for vitamin C (60 mg), each tablet clearly contains a much higher amount of vitamin C (500 mg).
All conditions of Additional Note 1 to Chapter 30 are therefore met and the product is to be classified as a medicament of Heading 3004 .
6.
Injectable preparation, sterile, pyrogen-free, consisting of purified collagen dispersed in a phosphate physiological saline buffered solution, whether or not containing lidocaine (INN), put up for retail sale
3004 90 00
Classficiation is determined by the provisions of general rules 1 and 6 for the interpretation of the combined nomenclature and the texts of CN codes 3004, 3004 90 and 3004 90 00.
This product is used in the treatment of atrophy due to disease, trauma or other disorders of the conjunctive tissue

---
Source: https://www.legislation.gov.uk/eur/1989/2061/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-1989-2061/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.